Fundraising Fox
Angela Zubel
InvestorChief Development Officer, Research & Development at Debiopharm Innovation Fund
Japan
Find your path to Angela
Sign up to see every warm intro you have to Angela
- Paths you didn't know you had: your email and LinkedIn already hold routes to Angela. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Chief Development Officer for R&D who joined Debiopharm International in 2019. She holds an MD from Jagiellonian University Krakow and a PhD from the German Cancer Research Center, with prior roles at Merck Serono, Novartis and Sandoz.
Colleagues at Debiopharm Innovation Fund
Frequently asked questions
- Who is Angela Zubel?
- Chief Development Officer for R&D who joined Debiopharm International in 2019. She holds an MD from Jagiellonian University Krakow and a PhD from the German Cancer Research Center, with prior roles at Merck Serono, Novartis and Sandoz.
- Where does Angela Zubel work?
- Angela Zubel is Chief Development Officer, Research & Development at Debiopharm Innovation Fund.
About this profile. Compiled from public sources — Debiopharm Innovation Fund's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights